fda approval status semax selank cerebrolysin noopept dihexa Approves Selumetinib for Adults With Neurofibromatosis Type 1 With Symptomatic, Inoperable Plexiform Neurofibromas NH Nootropics Selank .20% (240mcg/spray)
Description
Using them in sequence (lighter AHK-Cu spray first, followed by GHK-Curich creams or serums) allows each peptide to optimize a different aspect of skin biology
The resulting increase in intracellular NAD+ availability activates sirtuins particularly SIRT1, which regulates insulin sensitivity, gluconeogenesis, cholesterol synthesis, and fatty acid oxidation, and SIRT3, which governs mitochondrial antioxidant defences and energy metabolism
PMID: 25995620
Why it happens: Rapid weight loss shifts bodys cholesterol balance
These indicate either excessive dosing or sensitivity to the peptide
